UK Sleeping Bruxism Treatment Market

ID: MRFR/HC/47738-HCR
200 Pages
Vikita Thakur
Last Updated: April 06, 2026
UK Sleeping Bruxism Treatment Market Research Report: Size, Share, Trend Analysis By Types (Primary Bruxism, Secondary Bruxism), By Treatment (Dental Approaches, Medication), By Cause (Obstructive Sleep Apnea, Gastroesophageal Reflux Disease, Malocclusion, Sleep Paralysis), By Patient Type (Pediatric, Adult) and By End Users (Hospitals & Clinics, Dental Clinics) - Growth Outlook & Industry Forecast 2025 To 2035
UK Sleeping Bruxism Treatment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.5%
2024 Market Size$ 23.13 Million
2025 Market Size$ 24.63 Million
2035 Market Size$ 46.25 Million
Key Players
Procter & Gamble
GlaxoSmithKline
Johnson & Johnson
Colgate-Palmolive
Kerr Corporation
Dentsply Sirona
Trends
  • Rising Awareness and Diagnosis
  • Technological Advancements in Treatment
  • Integration of Holistic Approaches
Opportunities
  • Rising Stress Levels in Society
  • Growing Awareness of Oral Health
  • Increasing Prevalence of Bruxism
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Life Sciences, BY Type (USD Million)
      1. 4.1.1 Primary Bruxism
      2. 4.1.2 Secondary Bruxism
    2. 4.2 Life Sciences, BY Cause (USD Million)
      1. 4.2.1 Obstructive Sleep Apnea
      2. 4.2.2 Gastroesophageal Reflux Disease (GERD)
      3. 4.2.3 Malocclusion
      4. 4.2.4 Sleep Paralysis
    3. 4.3 Life Sciences, BY Treatment (USD Million)
      1. 4.3.1 Dental Approaches
      2. 4.3.2 Mouth Guard
      3. 4.3.3 NTI-TSS Device
      4. 4.3.4 Medication
      5. 4.3.5 Muscle Relaxants
      6. 4.3.6 Botulinum toxin type A Injections
      7. 4.3.7 Anti-anxiety Drugs
    4. 4.4 Life Sciences, BY Patient Type (USD Million)
      1. 4.4.1 Pediatric
      2. 4.4.2 Adult
      3. 4.4.3 Male
      4. 4.4.4 Female
    5. 4.5 Life Sciences, BY End User (USD Million)
      1. 4.5.1 Hospitals & Clinics
      2. 4.5.2 Dental Clinics
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Life Sciences
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Procter & Gamble (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 GlaxoSmithKline (GB)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Johnson & Johnson (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Colgate-Palmolive (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Kerr Corporation (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Dentsply Sirona (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 3M (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Oral-B (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 UK MARKET ANALYSIS BY TYPE
    3. 6.3 UK MARKET ANALYSIS BY CAUSE
    4. 6.4 UK MARKET ANALYSIS BY TREATMENT
    5. 6.5 UK MARKET ANALYSIS BY PATIENT TYPE
    6. 6.6 UK MARKET ANALYSIS BY END USER
    7. 6.7 KEY BUYING CRITERIA OF LIFE SCIENCES
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF LIFE SCIENCES
    10. 6.10 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
    12. 6.12 SUPPLY / VALUE CHAIN: LIFE SCIENCES
    13. 6.13 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
    14. 6.14 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million)
    15. 6.15 LIFE SCIENCES, BY CAUSE, 2024 (% SHARE)
    16. 6.16 LIFE SCIENCES, BY CAUSE, 2024 TO 2035 (USD Million)
    17. 6.17 LIFE SCIENCES, BY TREATMENT, 2024 (% SHARE)
    18. 6.18 LIFE SCIENCES, BY TREATMENT, 2024 TO 2035 (USD Million)
    19. 6.19 LIFE SCIENCES, BY PATIENT TYPE, 2024 (% SHARE)
    20. 6.20 LIFE SCIENCES, BY PATIENT TYPE, 2024 TO 2035 (USD Million)
    21. 6.21 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
    22. 6.22 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY CAUSE, 2025-2035 (USD Million)
      3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
      4. 7.2.4 BY PATIENT TYPE, 2025-2035 (USD Million)
      5. 7.2.5 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

UK Sleeping Bruxism Treatment Market Segmentation

UK Sleeping Bruxism Treatment Market By Type (USD Million, 2025-2035)

  • Primary Bruxism
  • Secondary Bruxism

UK Sleeping Bruxism Treatment Market By Cause (USD Million, 2025-2035)

  • Obstructive Sleep Apnea
  • Gastroesophageal Reflux Disease (GERD)
  • Malocclusion
  • Sleep Paralysis

UK Sleeping Bruxism Treatment Market By Treatment (USD Million, 2025-2035)

  • Dental Approaches
  • Mouth Guard
  • NTI-TSS Device
  • Medication
  • Muscle Relaxants
  • Botulinum toxin type A Injections
  • Anti-anxiety Drugs

UK Sleeping Bruxism Treatment Market By Patient Type (USD Million, 2025-2035)

  • Pediatric
  • Adult
  • Male
  • Female

UK Sleeping Bruxism Treatment Market By End User (USD Million, 2025-2035)

  • Hospitals & Clinics
  • Dental Clinics

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.